Ticker

TAK

TAKEDA PHARMS USA

8 catalysts on file

TAK

TAKEDA PHARMS USA

Approval Confirmed

Iclusig

319d ago Oct 10, 2025

openFDA verified 2mo ago

Countdown card →

TAK

Takeda Pharmaceutical Co Ltd

PDUFA AI-extracted

Oveporexton (TAK-861)

narcolepsy type 1

T-minus 36 days ~ Sep 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

TAK

Takeda Pharmaceutical Co Ltd

PDUFA AI-extracted

Rusfertide

Polycythemia Vera

T-minus 36 days ~ Sep 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

TAK

Takeda Pharmaceutical Co Ltd

Approval AI-extracted

Rusfertide

Polycythemia Vera

T-minus 36 days ~ Sep 30, 2026

SEC 6-K verified 2mo ago

Countdown card →

TAK

Takeda

Phase 2 Estimated

TAK-788

Carcinoma, Non-Small-Cell Lung

T-minus 67 days Oct 31, 2026

ClinicalTrials.gov verified 2mo ago

Countdown card →

TAK

Takeda

Phase 3 Estimated

TAK-755

Thrombotic Thrombocytopenic Purpura (TTP)

T-minus 203 days Mar 16, 2027

ClinicalTrials.gov verified 2mo ago

Countdown card →

TAK

Takeda

Phase 3 Estimated

Vedolizumab

Crohn's Disease

T-minus 287 days Jun 8, 2027

ClinicalTrials.gov verified 2mo ago

Countdown card →

TAK

Takeda Pharmaceutical Co Ltd

AdCom AI-extracted

Rusfertide

Polycythemia Vera

Date TBD Date TBD

SEC 6-K verified 2mo ago

Countdown card →